Animal models in the drug discovery pipeline for Alzheimer's disease

Por Van Dam, Debby, De Deyn, Peter Paul
Publicado em 2011

Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease

Por Wostyn, Peter, Van Dam, Debby, Audenaert, Kurt, De Deyn, Peter Paul
Publicado em 2011

Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method

Por Janssen, Leen, Sobott, Frank, De Deyn, Peter P., Van Dam, Debby
Publicado no MethodsX (2015)

The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer’s disease

Por Vermeiren, Yannick, Van Dam, Debby, Aerts, Tony, Engelborghs, Sebastiaan, Martin, Jean-Jacques, De Deyn, Peter P
Publicado no Alzheimers Res Ther (2015)

Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?

Por Van Dam, Debby, Vermeiren, Yannick, Dekker, Alain D., Naudé, Petrus J.W., De Deyn, Peter P.
Publicado no Curr Alzheimer Res (2016)

A new glaucoma hypothesis: a role of glymphatic system dysfunction

Por Wostyn, Peter, Van Dam, Debby, Audenaert, Kurt, Killer, Hanspeter Esriel, De Deyn, Peter Paul, De Groot, Veva
Publicado no Fluids Barriers CNS (2015)

Dilated Virchow-Robin spaces in primary open-angle glaucoma: a biomarker of glymphatic waste clearance dysfunction?

Por Wostyn, Peter, De Groot, Veva, Van Dam, Debby, Audenaert, Kurt, Killer, Hanspeter Esriel, De Deyn, Peter Paul
Publicado no Acta Radiol Open (2016)

Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Diseas...

Por Hudry, Eloise, Van Dam, Debby, Kulik, Wim, De Deyn, Peter P, Stet, Femke S, Ahouansou, Ornella, Benraiss, Abdellatif, Delacourte, André, Bougnères, Pierre, Aubourg, Patrick, Cartier, Nathalie
Publicado em 2009

Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer’s Disease (AD) Brain Regions: Differential Findings in AD with and without Depression

Por Dekens, Doortje W., Naudé, Petrus J.W., Engelborghs, Sebastiaan, Vermeiren, Yannick, Van Dam, Debby, Oude Voshaar, Richard C., Eisel, Ulrich L.M., De Deyn, Peter P.
Publicado no J Alzheimers Dis (2016)

The GABA(A) receptor is an FMRP target with therapeutic potential in fragile X syndrome

Por Braat, Sien, D'Hulst, Charlotte, Heulens, Inge, De Rubeis, Silvia, Mientjes, Edwin, Nelson, David L, Willemsen, Rob, Bagni, Claudia, Van Dam, Debby, De Deyn, Peter P, Kooy, R Frank
Publicado no Cell Cycle (2015)

A multidisciplinary approach unravels early and persistent effects of X-ray exposure at the onset of prenatal neurogenesis

Por Verreet, Tine, Quintens, Roel, Van Dam, Debby, Verslegers, Mieke, Tanori, Mirella, Casciati, Arianna, Neefs, Mieke, Leysen, Liselotte, Michaux, Arlette, Janssen, Ann, D’Agostino, Emiliano, Vande Velde, Greetje, Baatout, Sarah, Moons, Lieve, Pazzaglia, Simonetta, Saran, Anna, Himmelreich, Uwe, De Deyn, Peter Paul, Benotmane, Mohammed Abderrafi
Publicado no J Neurodev Disord (2015)